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This thesis deals with the advancement of oral immunization of wild boar, focussing on the 
creation of a new bait formulation. The basic objective of oral immunization is to enhance 
herd immunity and to eliminate the CSF pathogen within a short time frame. Higher bait 
uptake rates in gruntlings would on one hand lead to an increase of the seroprevalence rate in 
the wild boar population and on the other hand to a reduction of the number of susceptible 
animals. This would permit an even more effective control of CSF in the wild boar 
population.  
 
The uptake studies performed with domestic pigs and wild boar described in this exposition 
revealed, that gruntlings below four months of age only played with the baits and showed an 
incomplete uptake. By four months of age, the animals began to develop an active bait uptake 
initially showing a preference for the small baits (1.8 cm diameter). By the age of five to six 
months, the animals began to pick up the spheroidal 3 cm bait.  
The 3 cm bait was taken as a model for the creation of a new box vaccine container. In order 
to incorporate a sufficient amount of virus antigen into the bait, the vaccine  
(“C”-strain/CP7_E2alf) was lyophilised and filled into hard gelatine capsules which were then 
covered with the maize bait masse. Following investigations on the bait uptake, the 
lyophilised vaccine (we used the conventional “C”-strain and the chimeric pestivirus 
CP7_E2alf) was examined for its stability in comparison to the liquid formulation under 
different environmental conditions. It could be shown, that both vaccines are much more 
stable in the lyophilised than in the liquid form (p < 0,05). Due to the higher stability of 
lyophilised vaccine at temperatures over 20°C, the new formulation represents an 
improvement and is especially suitable for immunization campaigns carried out at higher 
environmental temperatures (in summer or in warmer regions). 
In the first part of the animal experiments carried out for the present thesis, the efficacy of the 
bait formulation containing lyophilised “C”-strain virus was studied. After administration of 
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the spheroidal vaccine baits to wild boar and domestic pigs followed by an infection with a 
low dose of CSFV strain “Alfort 187”, all vaccinated domestic pigs and wild boar were 
protected from a CSF infection and we were neither able to isolate challenge virus from BC 
nor from nasal mucous, eye fluid, saliva or faeces.  
In a second confirmatory trial, pigs were immunised with lyophilised “C”-strain and the 
spheroidal 3 cm bait and were subsequently subjected to a challenge infection with 1,000 
TCID50/ml.  
Again, the animals, which had picked up the bait completely, were protected from a lethal 
CSFV infection. Neither viremia nor virus shedding could be detected. The pigs developed 
high neutralising antibody titres. 
To conclude, the new bait-formulation consisting of: 
   a) a smaller bait (d = 3 cm) 
   b) a hard gelatine capsule with snap-lock and 
   c) lyophilised “C”-virus 
is able to protect pigs against a severe CSF infection and simultaneously prevent viremia and 
virus transmission. 
 
As in the future DIVA vaccines might have a positive impact on the control strategies against 
CSF in domestic pigs and wild boar, the development of new marker vaccine candidates also 
was one of the aims of an EU-project. 
Therefore, the last two animal experiments described in this thesis were performed in line 
with this project, using the chimeric marker vaccine CP7_E2alf in a lyophilised formulation 
with the bigger spheroidal bait and analogously to the experiments carried out with “C”-virus. 
In contrast to the “C”-strain, the freeze-dried chimera was not able to protect the infected pigs 
from a lethal infection. All vaccinees (wild boar and domestic pigs) became ill showing CSF 
typical symptoms. In the virological examination, virus was found in the blood as well as in 
all body fluids examined (nasal mucous, eye fluid, saliva and faeces), so that the animals died 
or had to be killed in a moribund state. 
We could not clarify conclusively whether the negative result of this animal experiment was 
due to low virus antigen content or rather the consequence of a non-optimal E1E2-
heterodimer-complex in the chimera. 
Based on these findings, another animal trial was performed with an improved CP7_E2alf 
chimera consisting of the E2-gene of CSF-strain “Alfort 187” and the E1-gene of this CSFV 
strain instead of the E1-gene of BVDV (CP7_E1E2alf). Besides this newly created virus the 
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previous chimera CP7_E2alf and the “C”-virus were used for parenteral vaccination. In 
animal experiments with domestic pigs, a complete protection from clinical signs and virus 
excretion could be observed with both chimeric pestiviruses and in the “C”-virus group after 
i.m. immunization. After vaccination, the weaner pigs developed neutralising antibodies, 
whereas at the time point of challenge the animals of the CP7_E1E2alf group reached the 
highest antibody titres in the virus neutralisation test, followed by the “C”-virus vaccinated 
and the CP7_E2alf immunised pigs. Because of the higher antibody titres in the CP7_E1E2alf 
group, it could be assumed that this construct with its CSF-E1E2-dimer is more effective with 
regard to the production of neutralising antibodies.  
Further studies on the efficacy of this new chimera after oral administration as well as on its 
stability and safety are not part of this thesis, but are regarded as important exploratory 
focuses for future research.  
 
With the new bait formulation it should be possible to reach a larger number of gruntlings by 
oral immunization. As a result, more animals will be protected against CSFV infection and in 
the consequence will not be able to serve as virus carriers spreading and shedding the CSF 
pathogen. Due to the improved stability of the lyophilised vaccine in comparison to the liquid 
suspension, the virus antigen content should not fall below the MID, even at high 
environmental temperatures and if the baits are not taken up for several days after 
distribution. This should lead to an effective immunization of wild boar over a long time 
period. 
 
If further scientific studies prove that the lyophilised CP7_E1E2alf chimera is efficient after 
oral administration, this vaccine can be considered as a classical DIVA vaccine candidate 
which allows to discriminate field-virus infected animals from vaccinated animals also in wild 
boar.  
 
 
 
 
 
 
 
 
